. 2021 Jul 19;11:665406. doi: 10.3389/fcimb.2021.665406

Table 2.

Anthropometric and metabolic parameters of all participants.

	L_CON	H_CON	L_PCOS	H_PCOS	P	P-adjusted
Age	27.28 ± 3.82	27.53 ± 3.82	25.74 ± 3.26	26.75 ± 4.16	0.298	/
WC	73.08 ± 6.49	75.36 ± 7.07	83.82 ± 11.18	87.09 ± 15.37	*＜0.001*	0.342
HC	91.89 ± 5.31	89.17 ± 8.36	98.54 ± 10.06	102.19 ± 14.07	*0.001*	0.084
BMI	20.72 ± 2.23	21.74 ± 2.51	25.06 ± 4.67	26.75 ± 8.27	*0.001*	/
WHR	0.79 ± 0.05	0.85 ± 0.06	0.84 ± 0.06	0.85 ± 0.06	*0.017*	0.074
SBP	110.61 ± 10.37	114 ± 11.43	117.03 ± 11.25	123.75 ± 12.37	*0.009*	0.211
DBP	67.89 ± 7.02^cd	69.73 ± 8.24^c	75.66 ± 7.35^ab	76.06 ± 8.67^a	*0.001*	*0.016*
FSH	8.8 ± 2.97^cd	8.1 ± 1.55	6.37 ± 1.75^a	6.03 ± 2.52^a	*＜0.001*	*0.015*
LH	5.44 ± 1.91^cd	5.31 ± 2.88^cd	10.67 ± 6.62^ab	9.07 ± 6.13^ab	*0.001*	*0.005*
PRL	13.55 ± 10.28	15.43 ± 10.06	13.61 ± 6.18	13.22 ± 5.71	0.856	0.777
E2	35.50 (24.75,50.00)	35.00 (23.00,51.00)	52.50 (37.75,65.00)	49.00 (32.25,73.50)	*0.008*	0.053
P	0.47 (0.34,0.73)	0.49 (0.36,0.68)	0.56 (0.28,0.99)	0.62 (0.36,1.19)	0.808	0.118
Ts	35.52 ± 15.55^cd	45.69 ± 25.5^cd	71.01 ± 24.86^ab	71.05 ± 24.56^ab	*＜0.001*	*＜0.001*
LH/FSH	0.68 ± 0.35^cd	0.66 ± 0.36^cd	1.65 ± 0.92^ab	1.54 ± 0.75^ab	*＜0.001*	*＜0.001*
AMH	3.94 ± 2.29^cd	2.96 ± 1.7^cd	10.5 ± 5.67^ab	9.8 ± 5.09^ab	*＜0.001*	*＜0.001*
GLU 0 h	4.93 ± 0.25	5.22 ± 0.32	5.19 ± 0.45	5.2 ± 0.33	0.064	0.188
GLU 30 min	6.92 ± 0.97	7.21 ± 1.12	7.55 ± 1.33	7.88 ± 1.21	0.105	0.267
GLU 2 h	5.63 ± 0.76^cd	6.46 ± 1.14^cd	7.47 ± 1.65^ab	7.94 ± 1.41^ab	*＜0.001*	*＜0.001*
INS 0 h	7.3 ± 3.39^d	9.14 ± 5.35^d	14.8 ± 8.61^d	21.81 ± 13.46a^bc	*＜0.001*	*0.01*
INS 30 min	51.52 ± 32.18	46.78 ± 21.79	85.6 ± 78.92	116.74 ± 68.64	*0.005*	0.232
INS 2 h	42.41 ± 21.03^d	44.74 ± 26.58^d	103.83 ± 76.51^d	158.1 ± 118.74^abc	*＜0.001*	*0.008*
HOMA IR	1.61 ± 0.79^d	2.15 ± 1.29^d	3.46 ± 2.11^d	5.14 ± 3.5^abc	*＜0.001*	*0.023*
TC	4.03 ± 0.41^bcd	5.75 ± 0.67^ac	4.61 ± 0.71^ab	5.96 ± 0.77^ac	*＜0.001*	*＜0.001*
TG	0.76 ± 0.29^bd	1.37 ± 1.07^a	1.35 ± 0.64	1.73 ± 0.77^a	*0.002*	*0.042*
HDLC	1.39 ± 0.18	1.43 ± 0.31	1.21 ± 0.29	1.27 ± 0.24	*0.022*	0.259
LDLC	2.09 ± 0.37^bcd	3.77 ± 0.26^ac	2.69 ± 0.49^abd	4.07 ± 0.71^ac	*＜0.001*	*＜0.001*
ApoA1	1.48 ± 0.2	1.52 ± 0.27	1.49 ± 0.39	1.52 ± 0.31	0.972	0.972
ApoB	0.59 ± 0.09^bcd	0.94 ± 0.16^acd	0.79 ± 0.18^abd	1.14 ± 0.26^abc	*＜0.001*	*＜0.001*
ApoB/ApoAI	0.41 ± 0.08^bd	0.64 ± 0.16^a	0.57 ± 0.21^d	0.79 ± 0.27^ac	*＜0.001*	*＜0.001*
TG/HDLC	0.56 ± 0.23	1.03 ± 0.9	1.24 ± 0.75	1.45 ± 0.79	*0.002*	0.141
LAP	11.76 ± 6.59	26.7 ± 31.51	39.19 ± 30.56	52.25 ± 37.51	*0.001*	0.255
VAI	1.02 ± 0.45	1.86 ± 1.57	2.35 ± 1.48	2.73 ± 1.51	*0.002*	0.134
CVAI	6.73 ± 18^bcd	23.38 ± 28.93^a	45.85 ± 40.43^a	62.24 ± 56.37^a	*＜0.001*	*0.018*

All data except E2 and P were normal distribution, and were analyzed by ANOVA, expressed as mean ± SD. E2 and P of non-normal distribution were analyzed by nonparametric Wilcoxon test and expressed as median with interquartile range (IQR). ^aP < 0.05 for statistically differently from L_CON. ^bP < 0.05 for statistically differently from H_CON. ^cP < 0.05 for statistically differently from L_PCOS. ^dP < 0.05 for statistically differently from H_PCOS. P-adjusted: adjusted for Age and BMI. The bold part in the table represents statistics, P < 0.05, with statistical significance.